My patient wants to perform strenuous endurance exercise. What’s the right advice? Fabian Sanchis-Gomar, Alejandro Santos-Lozano, Nuria Garatachea, Helios Pareja-Galeano, Carmen Fiuza-Luces, Michael J. Joyner, Alejandro Lucia PII: DOI: Reference:
S0167-5273(15)01315-7 doi: 10.1016/j.ijcard.2015.06.014 IJCA 20670
To appear in:
International Journal of Cardiology
Received date: Revised date: Accepted date:
18 February 2015 7 May 2015 12 June 2015
Please cite this article as: Sanchis-Gomar Fabian, Santos-Lozano Alejandro, Garatachea Nuria, Pareja-Galeano Helios, Fiuza-Luces Carmen, Joyner Michael J., Lucia Alejandro, My patient wants to perform strenuous endurance exercise. What’s the right advice?, International Journal of Cardiology (2015), doi: 10.1016/j.ijcard.2015.06.014
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
Manuscript resubmitted to International Journal of Cardiology
T
Title: My patient wants to perform strenuous endurance exercise. What's the right advice?
IP
Running title: Strenuous endurance exercise and the heart Authors:
NU
SC R
Fabian Sanchis-Gomar, MD, PhD1, Alejandro Santos-Lozano, PhD1, Nuria Garatachea, PhD2, Helios Pareja-Galeano, PhD1,3, Carmen Fiuza-Luces, PhD1,3,Michael J. Joyner, MD, PhD4, Alejandro Lucia, MD, PhD1,4
Research Institute of Hospital 12 de Octubre ('i+12'), Madrid, Spain
2
Faculty of Health and Sport Science, University of Zaragoza, Huesca, Spain
3
European University, Madrid, Spain
4
Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA
TE
D
MA
1
CE P
Manuscript Type: Short Review
AC
Word Count: 5105
Author for correspondence: Fabian Sanchis-Gomar, MD, PhD Research Institute of Hospital 12 de Octubre („i+12‟). Avda. de Córdoba s/n 28041 Madrid, Spain. Phone: +34 91 779 2784; Fax: +34 91 390 8544 E-mail:
[email protected] 1
ACCEPTED MANUSCRIPT
Manuscript resubmitted to International Journal of Cardiology
Abstract Prolonged strenuous endurance exercise (SEE) such as marathon running has recently
T
been associated with potential deleterious cardiac effects, particularly increased risk of
IP
atrial fibrillation (AF). This topic is medically important due to the increasing number
SC R
of participants in SEE events lasting several hours, including older people. The aim of this narrative review is to provide a summary of the evidence available on SEE and
NU
related issues such as cardiovascular mortality, AF, potential cardiac remodeling, cardiovascular events during exertion, or the need for pre-participation screening (with a
MA
special focus on beginners). This type of information can help physicians giving advice
D
to their patients and the general public regarding safe SEE practice.
TE
Key Words: strenuous endurance exercise; health; sudden cardiac death; atrial
AC
CE P
fibrillation; arrhythmia; pre-participation screening.
2
ACCEPTED MANUSCRIPT
Manuscript resubmitted to International Journal of Cardiology
Abbreviations and Acronyms AF = atrial fibrillation
T
AHA = American Heart Association
IP
CA = cardiac arrest
SC R
CHD = coronary heart disease CRF = cardiorespiratory fitness
ESC = European Society of Cardiology
MA
HCM = hypertrophic cardiomyopathy HR = hazard ratio
D
LA = left atrium
CE P
TE
LV = left ventricle PA = physical activity
NU
CVD = cardiovascular disease
RA = right atrium
RV = right ventricle
AC
SCD = sudden cardiac death
SEE = strenuous endurance exercise SMR = standard mortality ratio OR = odds ratio PPS = pre-participation screening
3
ACCEPTED MANUSCRIPT
Manuscript resubmitted to International Journal of Cardiology
Introduction The marathon running race (42.195km) commemorates the death of Pheidippides (530-
IP
T
490BC), a Greek messenger who is said to have died (perhaps of cardiac arrest (CA))
SC R
shortly after running from Marathon to Athens (~40km) to announce that the invading Persians had been defeated. Whether this event is myth or real, prolonged strenuous endurance exercise (SEE) has recently been hypothesized to have potential deleterious
NU
cardiac effects, and a „safety‟ threshold of ~1hour/day been recently postulated [1]. The “too much exercise” topic is medically important due to the increasing number of
MA
participants in SEE events lasting several hours. Thus, the aim of this narrative review is to summarize the evidence available so that physicians can adequately advise their
D
patients and the general public regarding SEE training and participation. We searched
TE
for publications on SEE and mortality, atrial fibrillation (AF), cardiac remodeling,
CE P
cardiovascular events and pre-participation screening (with no restriction on the starting date and up to April 30, 2015). The abovementioned terms were used primarily in the literature search, or combinations of 1 or more of these terms, with restrictions to
AC
English-language scientific articles (excluding congress abstracts) indexed in the Medline and Web of Science databases. We also extended the search spectrum to the “related articles”, and additional studies were identified from reference lists and the authors‟ knowledge of in press studies. Two authors independently assessed the records obtained for each of the main topics we addressed.
SEE and mortality Around ~1/3 of adults are essentially totally inactive [2], which remarkably increases the risk of chronic diseases and mortality [3]. Conversely, there is strong evidence that moderately-vigorous endurance („aerobic‟) exercise (e.g., brisk walking, intensity ~3-6
4
ACCEPTED MANUSCRIPT
Manuscript resubmitted to International Journal of Cardiology
metabolic equivalents (METs), with 1MET equaling resting energy expenditure, 3.5mLO2/kg/min) is associated with longer life expectancy, especially as weekly
T
exercise time increases to 450+min [4].
IP
The existence of a dose-response benefit of SEE remains more uncertain compared with
SC R
less intense exercise, although no dose-related harm has been convincingly demonstrated. In a 15-yr follow-up of 55,137 adult men/women, even low-volume
NU
running (50min/day of SEE [7]. A 21-yr follow-up showed that 538 runners of both genders
CE P
aged ≥50yrs and performing SEE~270min/week had 39% lower mortality than those engaging in ~70min/week [8]. A 7.7-yr longitudinal analysis of 35,402 male runners
AC
showed that, compared to 9km/day decreased angina (-65%), nonfatal CHD (-29%), and both fatal/nonfatal CHD risk (-26%) [9]. A recent prospective cohort study with 204,542 Australian adults aged 45-75yrs found that, among those who reported performing any physical activity (PA), engaging in SEE (e.g., jogging, cycling) was associated with risk reductions for all-cause mortality of 9% to 13%, even after adjusting for the total amount of PA [10]. Another recent prospective study on a large sample cohort reported that the upper threshold for all-cause mortality benefit occurred at 3 to 5 times the minimum 2008 PA Guidelines for Americans (150min of moderate-intensity PA, e.g., walking, or 75min of vigorous-intensity PA,
5
ACCEPTED MANUSCRIPT
Manuscript resubmitted to International Journal of Cardiology
e.g., brisk walking, jogging) and showed no evidence of harm at 10+ times the recommended minimum [11].
T
Exercise-related CVD-mortality benefits are still present in extreme endurance
IP
exercisers. A recent meta-analysis estimated a 27% lower CVD standard mortality ratio
SC R
(SMR) in elite athletes (n=12,119, mostly men, including Tour de France finishers or former Olympic marathoners), compared with the general population [12]. Albeit the
NU
heterogeneity of athletes‟ specialties (endurance but also „explosive‟/„power‟ sports) is a major limitation, these findings do not support the notion that SEE above some sort of
MA
safety threshold may lead to a chronic cardiac damage that would ultimately limit the longevity benefits of exercise. A recent 50-yr follow-up of Finnish athletes found higher
D
life expectancy in endurance athletes (79.1 yrs;95%CI:76.6-80.6) than in controls
TE
(72.9yrs;95%CI:71.8-74.3) [13]. Data from 49,219 men and 24,403 women participating in 90km or 30km cross-country ski races, respectively, showed a CVD-
CE P
SMR of 0.43 (95%CI:0.35-0.51), with the lowest SMRs found amongst older participants and those who participated in several races [14].
AC
Long-term SEE and AF Light-moderate exercise (e.g., walking) is associated with lower AF risk in older adults [15]. A recent meta-analysis in non-athletes (n=96,526) found no significant association between regular exercise and higher AF risk compared with sedentary lifestyle (odds ratio (OR)=1.08;95%CI:0.97-1.21) [16]. A recent pooled analysis of 4 studies (n=112,784 participants) showed no association between increasing amount of time spent on exercise and AF (0.95;95%CI:0.72-1.26) [17]. In contrast, long-term practice of SEE can be associated with higher risk of AF, particularly lone AF [18-22]. Although
6
ACCEPTED MANUSCRIPT
Manuscript resubmitted to International Journal of Cardiology
there is no universal consensus [23,24], the association seems stronger in highly competitive athletes.
IP
T
A meta-analysis including 655 athletes and 895 controls found a 5.29-fold higher risk (95%CI:3.57-7.85) in the former [25]. A longitudinal study of 309,540
SC R
Norwegian men and women aged 40-45yrs showed that men who reported SEE were more often prescribed flecainide than sedentary people (HR=3.14;95%CI:2.17-4.54)
NU
[26]. In 52,755 long-distance cross-country skiers, higher competition and experience level were associated with higher risk of any arrhythmias (HR=1.30;95%CI:1.04-1.62)
MA
and AF (HR=1.20;95%CI:0.93-1.55) [27]. A recent meta-analysis also found a significant association between history of sports participation and AF risk (1.98;
D
95%CI:1.00–3.94) [17]. Elderly men with a history of long-term SEE practice had a 6%
TE
higher AF risk (95%CI:0.8-11.1) compared with elderly men in the general population
CE P
[28]. Grabs et al recently performed continuous ECG monitoring in 20 male runners (age 45±8yrs) during a marathon race [29]. Interestingly, the prevalence of arrhythmias (atrial and ventricular premature complexes) decreased during and after the run and no
AC
malignant arrhythmias were reported. Potential factors triggering AF in previously healthy long-term exercisers include left-atrial (LA) enlargement or fibrosis, increased parasympathetic tone and inflammation [30-33]. Self-reporting of AF is a significant limitation of some studies in this field [28], since this might include not only paroxysmal (vs. stable) AF, but also palpitations and other symptoms that might be erroneously interpreted as AF by sportspeople. Other types of arrhythmias (e.g., ventricular tachycardia) which are relatively common in CVD/CHD-free people who are starting to practice exercise can also be interpreted as palpitations.
7
ACCEPTED MANUSCRIPT
Manuscript resubmitted to International Journal of Cardiology
Long-term SEE-induced remodeling? SEE sports events (marathon, half-ironman triathlon, full-ironman triathlon, alpine
IP
T
bicycle racing) can cause acute cardiac changes such as RA and right ventricle (RV)
SC R
dilation, accompanied by decreased RV ejection fraction and elevation of biomarkers of myocardial stress/injury (troponin, B-type natriuretic peptide) [7,34,35], with an apparent dose-effect of event duration [34,35]. A recent meta-analysis found that RV
NU
function is the most impaired variable post-SEE, while left ventricle (LV) function is relatively unaffected [36]. Short-term recovery of the SEE-induced disturbances is
MA
usually complete, with no evidence of actual tissue damage [37-39]. However, LV or RV diastolic dysfunction might persist in some participants for 1 [35,40] up to ~4wk
D
post-race [41]. No significant post-marathon changes in cardiac-troponin have been
TE
reported in old experienced (>60yrs) runners [42]. When these do occur in older
CE P
runners, post-marathon alterations follow a similar pattern compared to younger runners [43], and return to normal within 2wk [43]. Post-marathon occurrence [44] or persistence of cardiac alterations were found to be more frequent in less trained runners
AC
(65yrs) endurance athletes were found to have preserved, youthful
NU
levels of LV compliance and distensibility [53,54] and highly trained endurance runners (33-65yrs) demonstrated greater dilating capacity of their epicardial coronary arteries
MA
compared with inactive men [55].
Solid evidence is lacking that athlete‟s heart remodeling leads to long-term
D
CVD, but this possibility, especially RV enlargement, cannot be excluded in some high-
TE
level athletes and deserves further scrutiny [48]. On the other hand, unsuitable cardiac
CE P
remodeling is unlikely to affect runners with a lower training/competition level. In sedentary people who trained intensively for 12 months to compete in a marathon, the LV showed concentric remodeling during the first 6-9 months, and thereafter dilated
AC
and restored the baseline mass-to-volume ratio whereas the RV responded with a balanced remodeling throughout the program [56].
SEE and cardiovascular events The relative risk of sudden cardiac death (SCD) increases 16.9-fold during or up to 30min after exercise at ≥6METs intensity, but the absolute risk is extremely low (1/1.51M episodes of exertion) and further decreases with habitual exercise [57]. SEErelated SCD is considerably less frequent compared to non-sports related SCD, e.g., 1.12/100,000 athlete-years over 6yrs in Danish athletes (aged 12-35yrs) vs. 3.76/ 100,000 person-yr in the general population [58]. The recently reported incidence of 9
ACCEPTED MANUSCRIPT
Manuscript resubmitted to International Journal of Cardiology
SCD in US was 0.39 [59] or 0.75/100,000 runners for half-marathons/marathons [60] and 1.5/100,000 participants for triathlons [61]. The incidence proportion of CA in
T
recent US marathons (2000-2010) [59] and in a 90-yr follow-up of a 90km ski-race in
IP
Sweden was 1.01/100,000 runners and 2.16/100,000 skiers [59]. Middle-aged men
SC R
(especially poorly trained runners) were the high-risk group, and hypertrophic cardiomyopathy (HCM) and CHD (especially the former in runners [59]) were the
NU
major predisposing cause. Although CA mainly occurred during the last quarter for runners, it was more frequent in the first third of the ski race, suggesting the existence
MA
of different trigger mechanisms for CA induction in different temperatures. An interesting comparison between running and ski races was that the fatality rates were
D
75% and 71%, respectively, with initiation of bystander-administered cardiopulmonary
TE
resuscitation during the first minutes being strong survival predictors.
CE P
The increasing popularity of extreme endurance sports has resulted in a growing number of poorly trained participants with underlying CVD, and this might have contributed to the growth of SEE-related CA over the last decade [59], thus supporting
AC
the importance of establishing reliable preventive screening.
Pre-participation screening (PPS) PPS aimed to identify athletes at risk of SCD or disease progression due to sports participation [62,63], is recommended by major medical and sporting societies, the American Heart Association (AHA) [63], the European Society of Cardiology (ESC) [64], and the International Olympic Committee [65]. Although there is an ongoing debate regarding the actual preventive value of PPS, and especially which screening strategy is more effective, the inclusion of ECG should be promoted [62]. Screening young athletes with 12-lead ECG together with cardiovascular-focused history and 10
ACCEPTED MANUSCRIPT
Manuscript resubmitted to International Journal of Cardiology
physical examination may be cost-effective [66]. Baseline ECG screening reduced the incidence of SCD by 89% in young Italian athletes [67]. However, this positive
T
outcome could not be replicated in other cohort studies [68,69]. Modern imaging
IP
techniques can certainly improve our understanding of the athlete's heart, e.g., by
SC R
determining the prognostic relevance of small patches of delayed gadolinium enhancement in highly-trained athletes. Nonetheless, there is yet no accumulated
NU
evidence to support their inclusion in athletes‟ PPS [70].
The growing number of non-competitive participants engaging in SEE has
MA
increased the importance of PPS for this population, and poses problems in terms of logistics and incremental cost [71]. The overall predictive value of exercise-ECG for
D
SEE-related cardiovascular appears limited, e.g., with a reported 18% sensitivity and
TE
92% specificity of positive test results in asymptomatic, hypercholesterolemic men aged
CE P
35–59yrs [72]. Despite the lack of solid scientific data to guide PSS in non-competitive athletes, several Associations of Cardiology and Sports Medicine have addressed the issue by consensus [73,74] with a common recommendation that individuals at a higher
AC
CHD risk, e.g., those with diabetes mellitus, undergo maximal exercise testing before engaging in SEE [71]. In contrast, the US Preventive Services Task Force has stated that there is insufficient evidence supporting screening with exercise testing [75]. A PPS flowchart for middle-aged/senior individuals engaged in leisure SEE has been proposed by the European Association of Cardiovascular Prevention and Rehabilitation including [74]: (i) thorough risk assessment with history, physical examination, baseline ECG and risk score assessment within 10yrs using the ESC Systematic Coronary Risk Evaluation (SCORE, based on age, sex, blood pressure, blood cholesterol, and smoking history) [76,77]; followed by ii) maximal exercise testing, but only in individuals with high risk of coronary events. 11
ACCEPTED MANUSCRIPT
Manuscript resubmitted to International Journal of Cardiology
Master athletes (40+yrs), especially men, represent a special concern. The AHA Science advisory committee recommends PPS with thorough family history and
T
physical examination with the main purpose of detecting previously undiagnosed CHD,
IP
and those with a moderate-to-high CHD risk should undergo exercise testing [78].
SC R
These „risk‟ athletes include men aged >40-45yrs or women >50-55yrs (or postmenopausal) with ≥1 independent coronary risk factor (hypercholesterolemia/
NU
dyslipidemia, hypertension, current/recent cigarette smoking, diabetes mellitus, or history of myocardial infarction or SCD in a first-degree relative